Intrexon Actobiotics SA
Intrexon Actobiotics reported total assets of €8.76m at the end of the 2025 financial year (annual accounts filed with the NBB on 03 Jul 2026).
The score of Intrexon Actobiotics shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -24 % Total assets -33 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Intrexon Actobiotics's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 03 Jul 2026
- Year ended 31 Dec 2024filed on 28 Jul 2025
- Year ended 31 Dec 2023filed on 02 Oct 2024
- Year ended 31 Dec 2022filed on 18 Jul 2023
- Year ended 31 Dec 2021filed on 18 Jul 2022
Intrexon Actobiotics's financial analysis
- Solvency98.0%sector median: 61.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Intrexon Actobiotics
Intrexon Actobiotics's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0882.251.820
- VAT number
- BE0882251820
- Peppol
- Registered · 0208:0882251820 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 03 Jul 2006
- Registered office
- 9810 Nazareth-De Pinte
- Latest accounts
- 2025 · filed on 03 Jul 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Intrexon Actobiotics (SA) has been based in Nazareth-De Pinte since 2006, active in: research and experimental development on biotechnology. For 2025, it reports a net loss of 372,153 € and equity of €8.59m; its revenue is not published. Its solvency stands at 98.0%, above the median of its sector (61.7%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Intrexon Actobiotics
Companies in the same business, of comparable size and area, outside its group.
- AstriVax Therapeutics Research and experimental development on natural sciences and engineering Leuven · balance sheet €12.5m
- The Akkermansia Company Research and experimental development on natural sciences and engineering Mont-Saint-Guibert · balance sheet €16.9m
- OSIVAX Belgique Research and experimental development on natural sciences and engineering Liège · balance sheet €17.0m
- EXO Biologics Research and experimental development on natural sciences and engineering Liège · balance sheet €11.7m
- ConvEyXo Research and experimental development on natural sciences and engineering Charleroi · balance sheet €10.3m
- XpressBioX Manufacture of basic pharmaceutical products Herstal · balance sheet €8.92m
- Aquilon Pharmaceuticals Research and experimental development on natural sciences and engineering Seraing · balance sheet €11.1m
- Biotalys Research and experimental development on natural sciences and engineering Ghent · balance sheet €16.3m
Frequently asked questions about Intrexon Actobiotics
What is the revenue of Intrexon Actobiotics?
Intrexon Actobiotics files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Intrexon Actobiotics?
In Belgium, the VAT number is the company number prefixed with BE: BE0882251820 for Intrexon Actobiotics, if the company is VAT-registered. Its company number (CBE) is 0882.251.820.
Where is the registered office of Intrexon Actobiotics?
According to the CBE register, the registered office of Intrexon Actobiotics is in 9810 Nazareth-De Pinte.
What is the equity of Intrexon Actobiotics?
At the close of the 2025 financial year, the equity of Intrexon Actobiotics amounts to 8,592,009 €, a solvency of 98.0% of total assets.
Who manages Intrexon Actobiotics?
The register lists 2 active mandates at Intrexon Actobiotics. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Intrexon Actobiotics
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →